ACROBiosystems社 Which animal model can help defeat COVID-19?
The spike protein of SARS-CoV-2 facilitates viral entry into the target cell exploiting the Angiotensin-converting enzyme 2 (ACE2) receptor. The ACE2 gene is highly conserved in mammalian animals at the DNA and peptide level, which makes them the potential hosts for SARS-CoV-2. At ACROBiosystems, we verified the binding activity between different species of ACE2 and S1 or S RBD proteins using ELISA/SPR/BLI. Check out which one will be the suitable animal model. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
※ Bioactivity-BLI We investigated the binding activity between the ACE2 of human, cynomolgus or paguma larvata, and the S RBD of SARS-CoV-2 using BLI. The binding activities of human and cynomolgus ACE2 to the S RBD of SARS-CoV2 are much higher than paguma larvata ACE2. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
※ Bioactivity-ELISA Paguma larvata is an important host of SARS. Its ACE2 receptor protein also showed a very good binding ability to the S protein of SARS-CoV-2, though not comparable to human and cynomolgus ACE2. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
※ Bioactivity-SPR An SPR method was also used to investigate the binding affinity between paguma larvata ACE2 and S RBD or S1 protein of SARS and SARS-CoV-2. Based on the results, we concluded that paguma larvata ACE2 is more susceptible to SARS. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product List
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reference: [2] Stawiski et al., 2020 Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility. doi: http://life.acrobiosystems.cn/e/535472/10-1101-2020-04-07-024752/2dvml2n/919136533?h=gTzj8imS4yO1h7_OQo8L-d7H5Io6YwQ2DgGxOe_YAUQ |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。